Author

Yutaka Takaoka

University of Toyama, Professor - Cited by 830 - Computational Medical Science

Biography

Dr. Yutaka Takaoka currently present as a Professor and Director, University of Toyama: Toyama, JP. Earlier worked at the Division of Medical Informatics and Bioinformatics, Kobe University Hospital, Kobe 650-0017, Japan. Exp[ert in the field of Health Informatics, Physical Therapy, Rehabilitation etc.
Title
Cited by
Year
Development of an exon skipping therapy for X-linked Alport syndrome with truncating variants in COL4A5
T Yamamura, T Horinouchi, T Adachi, M Terakawa, Y Takaoka, K Omachi, ...Nature communications 11 (1), 2777, 2020202
55
2020
Identification of mutations in FN1 leading to glomerulopathy with fibronectin deposits
H Ohtsubo, T Okada, K Nozu, Y Takaoka, A Shono, K Asanuma, L Zhang, ...Pediatric Nephrology 31, 19-1467, 2016201
45
2016
Susceptibility to serious skin and subcutaneous tissue disorders and skin tissue distribution of sodium-dependent glucose co-transporter type 2 (SGLT2) inhibitors
T Sakaeda, S Kobuchi, R Yoshioka, M Haruna, N Takahata, Y Ito, ...International journal of medical sciences 15 (9), 937, 2018201
29
2018
Differences in clinical phenotype among patients with XP complementation group D: 3D structure and ATP-docking of XPD in silico.
E Nakano, R Ono, T Masaki, S Takeuchi, Y Takaoka, E Maeda, ...The Journal of investigative dermatology 134 (6), 1775-1778, 2014201
22
2014
Shakuyaku-kanzo-to (Shao-Yao-Gan-Cao-Tang) as treatment of painful muscle cramps in patients with lumbar spinal stenosis and its minimum effective dose
Y Takao, Y Takaoka, A Sugano, H Sato, Y Motoyama, M Ohta, ...Kobe J Med Sci 61 (5), E132-7, 151
20
2015
Docking analysis and the possibility of prediction efficacy for an anti-IL-13 biopharmaceutical treatment with tralokinumab and lebrikizumab for bronchial asthma
Y Nakamura, A Sugano, M Ohta, Y TakaokaPloS one 12 (11), e0188407, 202
17
2017
Categorization of 77 dystrophinexons into 5 groups by a decision tree using indexes of splicing regulatory factors as decision markers
RG Malueka, Y Takaoka, M Yagi, H Awano, T Lee, EK Dwianingsih, ...BMC genetics 13, 1-10, 2012201
17
2012
CSP-1103 (CHF5074) stabilizes human transthyretin in healthy human subjects
L Qiang, Y Guan, X Li, L Liu, Y Mu, A Sugano, Y Takaoka, T Sakaeda, ...Amyloid 24 (1), 42-51, 2017201
15
2017
CHF5074 (CSP-1103) stabilizes human transthyretin in mice humanized at the transthyretin and retinol-binding protein loci
Y Mu, S Jin, J Shen, A Sugano, Y Takaoka, L Qiang, BP Imbimbo, ...FEBS letters 589 (7), 849-856, 202
15
2015
Genetic background, recent advances in molecular biology, and development of novel therapy in Alport syndrome
K Nozu, Y Takaoka, H Kai, M Takasato, K Yabuuchi, T Yamamura, ...Kidney Research and Clinical Practice 39 (4), 402, 2020202
14
2020
Identification of a heterozygous p.Gly568Val missense mutation in the TRPV3 gene in a Japanese patient with Olmsted syndrome: In silico analysis of TRPV3
H Nagai, Y Takaoka, A Sugano, Y Nakamachi, S Kawano, C NishigoriThe journal of dermatology 44 (9), 1059-1062, 2017201
13
2017
Co-precipitation molecules hemopexin and transferrin may be key molecules for fibrillogenesis in TTR V30M amyloidogenesis
M Ohta, A Sugano, N Hatano, H Sato, H Shimada, H Niwa, T Sakaeda, ...Transgenic research 27, 15-23, 2018201
12
2018
Analysis of a single-codon E746 deletion in exon 19 of the epidermal growth factor receptor
M Ogasawara, Y Nakamura, N Morikawa, H Nitanai, S Moriguchi, R Chiba, ...Cancer chemotherapy and pharmacology 77, 19-29, 2016201
10
2016
Paramyotonia congenita: From clinical diagnosis to in silico protein modeling analysis
DK Nurputra, T Nakagawa, Y Takeshima, ISK Harahap, S Morikawa, ...Pediatrics International 54 (5), 602-612, 2012201
10
2012
Molecular pathology of Sandhoff disease with p. Arg505Gln in HEXB: application of simulation analysis
N Yasui, Y Takaoka, H Nishio, DK Nurputra, K Sekiguchi, H Hamaguchi, ...Journal of human genetics 58 (), 611-617, 2013201
9
2013
Core body temperature changes in school-age children with circadian rhythm sleep–wake disorder
S Kimura, Y Takaoka, M Toyoura, S Kohira, M OhtaSleep Medicine 8, 9-104, 2021202
7
2021
Prediction of infectivity of SARS-CoV2: Mathematical model with analysis of docking simulation for spike proteins and angiotensin-converting enzyme 2
Y Takaoka, A Sugano, Y Morinaga, M Ohta, K Miura, H Kataguchi, ...Microbial Risk Analysis 22, 100227, 2022202
6
2022
Prevalence effect in haptic search
K Ishibashi, K Watanabe, Y Takaoka, T Watanabe, S Kitai-Perception 3 (8), 495-498, 2012201
6
2012
Indigo plant leaf extract inhibits the binding of SARS‑CoV‑2 spike protein to angiotensin‑converting enzyme 2
M Hagiyama, F Takeuchi, A Sugano, A Yoneshige, T Inoue, A Wada, ...Experimental and Therapeutic Medicine 23 (4), 1-8, 2022202
6
2022
Genotype-phenotype correlation in WT1 exon 8 to 9 missense variants
Y Takaoka, K Kamei, R Hamada, D Ichikawa, K Tanaka, Y Aoto, S Ishiko, ...Kidney International Reports 6 (8), 2114-2121, 2021202
5
2021

Referred From: https://scholar.google.com/citations?user=miOS-rcAAAAJ

Cited by
Citations 830
h-index 17
i10-index 29
Recommended Journals
Open Access Journals